JP2024534178A5 - - Google Patents
Info
- Publication number
- JP2024534178A5 JP2024534178A5 JP2024513275A JP2024513275A JP2024534178A5 JP 2024534178 A5 JP2024534178 A5 JP 2024534178A5 JP 2024513275 A JP2024513275 A JP 2024513275A JP 2024513275 A JP2024513275 A JP 2024513275A JP 2024534178 A5 JP2024534178 A5 JP 2024534178A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- nucleic acid
- acid sequence
- fusion protein
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163239278P | 2021-08-31 | 2021-08-31 | |
| US63/239,278 | 2021-08-31 | ||
| US202263392778P | 2022-07-27 | 2022-07-27 | |
| US63/392,778 | 2022-07-27 | ||
| PCT/US2022/075645 WO2023034783A1 (en) | 2021-08-31 | 2022-08-30 | Tuberculosis vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534178A JP2024534178A (ja) | 2024-09-18 |
| JP2024534178A5 true JP2024534178A5 (https=) | 2025-08-25 |
Family
ID=83447900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513275A Pending JP2024534178A (ja) | 2021-08-31 | 2022-08-30 | 結核ワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240350607A1 (https=) |
| EP (1) | EP4396208A1 (https=) |
| JP (1) | JP2024534178A (https=) |
| KR (1) | KR20240049802A (https=) |
| AU (1) | AU2022339918A1 (https=) |
| CA (1) | CA3226978A1 (https=) |
| CL (1) | CL2024000600A1 (https=) |
| CO (1) | CO2024001517A2 (https=) |
| IL (1) | IL310667A (https=) |
| MX (1) | MX2024001964A (https=) |
| TW (1) | TW202328167A (https=) |
| WO (1) | WO2023034783A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118662620A (zh) * | 2023-03-15 | 2024-09-20 | 康希诺生物股份公司 | 一种肺结核疫苗及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| DK2457926T3 (da) | 2005-04-29 | 2015-01-05 | Glaxosmithkline Biolog Sa | Ny fremgangsmåde til forebyggelse eller behandling af M. tuberkulose-infektion |
| AU2011230619C1 (en) | 2010-03-25 | 2016-06-23 | Oregon Health & Science University | CMV glycoproteins and recombinant vectors |
| TR201802741T4 (tr) | 2010-05-14 | 2018-03-21 | Univ Oregon Health & Science | Rekombinant hcmv ve rhcmv vektörleri ve bunların kullanımları. |
| HUE037408T2 (hu) | 2011-06-10 | 2018-08-28 | Univ Oregon Health & Science | CMV glikoproteinek és rekombináns vektorok |
| DK2964769T3 (en) | 2013-03-05 | 2018-12-10 | Univ Oregon Health & Science | Cytomegalovirus vectors enabling control of T cell targeting |
| JP6816031B2 (ja) | 2015-02-10 | 2021-01-20 | オレゴン ヘルス アンド サイエンス ユニバーシティ | 非標準的なｃｄ８＋ｔ細胞応答を生成するのに有用な方法および組成物 |
| GB201513176D0 (en) * | 2015-07-27 | 2015-09-09 | Glaxosmithkline Biolog Sa | Novel methods for inducing an immune response |
| CN108474003A (zh) | 2015-11-20 | 2018-08-31 | 俄勒冈健康与科学大学 | 包含微小rna识别元件的cmv载体 |
| CN109843321A (zh) * | 2016-06-22 | 2019-06-04 | 国际艾滋病疫苗行动组织公司 | 作为结核病疫苗的重组巨细胞病毒载体 |
| US10532099B2 (en) | 2016-10-18 | 2020-01-14 | Oregon Health & Science University | Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules |
-
2022
- 2022-08-30 CA CA3226978A patent/CA3226978A1/en active Pending
- 2022-08-30 KR KR1020247005374A patent/KR20240049802A/ko active Pending
- 2022-08-30 TW TW111132746A patent/TW202328167A/zh unknown
- 2022-08-30 US US18/687,463 patent/US20240350607A1/en active Pending
- 2022-08-30 AU AU2022339918A patent/AU2022339918A1/en active Pending
- 2022-08-30 EP EP22777533.5A patent/EP4396208A1/en active Pending
- 2022-08-30 JP JP2024513275A patent/JP2024534178A/ja active Pending
- 2022-08-30 IL IL310667A patent/IL310667A/en unknown
- 2022-08-30 WO PCT/US2022/075645 patent/WO2023034783A1/en not_active Ceased
- 2022-08-30 MX MX2024001964A patent/MX2024001964A/es unknown
-
2024
- 2024-02-13 CO CONC2024/0001517A patent/CO2024001517A2/es unknown
- 2024-02-27 CL CL2024000600A patent/CL2024000600A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110862435B (zh) | 非洲猪瘟ctl表位多肽及其应用 | |
| CN111533809A (zh) | 针对新型冠状病毒的亚单位疫苗及应用 | |
| Ren et al. | Design and evaluation of a multi-epitope assembly peptide vaccine against Acinetobacter baumannii infection in mice | |
| CN115246874B (zh) | 一种重组新型冠状病毒s-rbd三聚体蛋白、其制备方法和应用 | |
| Stohwasser et al. | Molecular characterization of the RNA S segment of nephropathia epidemica virus strain Hällnäs B1 | |
| KR20120083899A (ko) | 마이코박테리아 백신들 | |
| US20230242627A1 (en) | Composition and method for activating latent human immunodeficiency virus (hiv) | |
| JP2009529576A5 (https=) | ||
| DK2453914T3 (en) | ANTIGEN-SPECIFIC MULTIPLE PIT-BASED ANTI-INFECTIOUS VACCINES | |
| WO2023138334A1 (zh) | 一种重组新型冠状病毒蛋白疫苗、其制备方法和应用 | |
| KR20210133225A (ko) | 부착된 이종 분자를 car-세포의 비천연 nkg2d 수용체에 선택적으로 전달하는 변형된 비천연 nkg2d 리간드 | |
| JP2023522154A5 (https=) | ||
| JP2024537250A5 (https=) | ||
| JP2019134707A (ja) | 免疫調節 | |
| JP2024534178A5 (https=) | ||
| WO2006085583A1 (ja) | 細胞透過性ペプチド | |
| JP2010535504A5 (https=) | ||
| CA2327353A1 (en) | Structural proteins of fish pancreatic disease virus and uses thereof | |
| CN113365655A (zh) | 包含糖基化ag85a蛋白的用于预防结核病的疫苗组合物及其制备方法 | |
| JP2024534189A5 (https=) | ||
| US20050261227A1 (en) | Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines | |
| KR101570453B1 (ko) | 돼지 유행성 설사 바이러스의 재조합 스파이크 1 단백질을 발현하는 재조합 세포 | |
| Brand et al. | Novel Drosophila melanogaster genes encoding RRM-type RNA-binding proteins identified by a degenerate PCR strategy | |
| WO2023138333A1 (zh) | 一种重组新型冠状病毒蛋白疫苗、其制备方法和应用 | |
| JP2025514872A5 (https=) |